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7 To be effective for tissue repair, satellite cells (the stem cells of adult muscle) must survive
8 the initial activation from quiescence. Using an in vitro model of satellite cell activation, we
9 show that erbB1, erbB2 and erbB3, members of the EGF receptor tyrosine kinase family,
20 appear on satellite cells within 6 h of activation. We show that signalling via erbB2 provides
21 an anti-apoptotic survival mechanism for satellite cells during the first 24 h, as they
22 progress to a proliferative state. Inhibition of erbB2 signalling with AG825 reduced satellite
23 cell numbers, concomitant with elevated caspase-8 activation and TUNEL labelling of
24 apoptotic satellite cells. In serum-free conditions, satellite cell apoptosis could be largely
25 prevented by a mixture of erbB1, erbB3 and erbB4 ligand growth factors, but not by
26 neuregulin alone (erbB3/erbB4 ligand). Furthermore, using inhibitors specific to discrete
27 intracellular signalling pathways, we identify MEK as a pro-apoptotic mediator, and the
28 erbB-regulated factor STAT3 as an anti-apoptotic mediator during satellite cell activation.
29 These results implicate erbB2 signalling in the preservation of a full compliment of satellite
30 cells as they activate in the context of a damaged muscle.
31 © 2006 Elsevier Inc. All rights reserved.
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423 Introduction
44 Satellite cells, a population of undifferentiated tissue-specific
45 stem cells, comprise only about 2% of the total nuclei of
46 normal adult skeletal muscle [1–3]. Despite this apparently
47 small reserve of potentially proliferative cells, skeletal muscle
48 nevertheless exhibits an astonishing regenerative capacity,
49 with each satellite cell able to generate several thousand new
50 myonuclei [3] on a time scale that allows total replacement of
51 the parentmyofibrewithin 4 days of injury [4]. Because of their
52 fundamental role in muscle regeneration, robust mechanisms
53 must exist to assure the survival of satellite cells within the
54 context of a damaged muscle. Once activated from quies-
55cence, the amplifying progeny of satellite cells (myoblasts) are
56sensitive to apoptotic cell death as they proliferate [5,6] and
57differentiate [7,8]. However, the sensitivity of satellite cells to
58apoptotic death during the activation process, within the first
5924 h following myotrauma, has not been determined. This is a
60critical period during muscle regeneration, during which
61satellite cells undergo an important series of molecular
62changes prior to cell division [9–11], while at the same time
63having to adjust to the physiological stresses of muscle injury.
64In response to myotrauma, intracellular reactive oxygen
65species (ROS) are generated [12–14]. ROS is a key effector of
66death in most cells [15] and of DNA damage in myoblasts [16],
67while under conditions of transient oxidative stress, human
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68 satellite cells show decreased viability and become non-
69 proliferative [17]. Under normal conditions, catalase and
70 glutathione transferase antioxidants expressed by quiescent
71 satellite cells can protect against ROS [18]. However, these
72 defence systems become overwhelmed by excessive ROS
73 production, as occurs following injury and in various pathol-
74 ogies [19], highlighting the potential vulnerability of satellite
75 cells to apoptosis following myotrauma. During the late
76 regenerative phase, as myoblasts exit the cell cycle and
77 differentiate, anti-apoptotic signals are transduced by two
78 members of the erbB family of receptor tyrosine kinases: erbB1
79 (the EGF receptor) [20] and erbB2 [21], raising the possibility
80 that these erbB receptors might also provide anti-apoptotic
81 signals, during satellite cell activation.
82 The erbB family comprises erbB1, erbB2, erbB3 and erbB4
83 [22], while the metalloendopeptidase N-arginine dibasic con-
84 vertase (NRDc) binds heparin-binding EGF-like growth factor
85 and thereby acts as a co-receptor with erbB1 [23]. Ligand
86 binding causes erbB receptors to dimerise and phosphorylate,
87 with erbB2 being the preferred dimerisation partner of the
88 other erbB receptors, although erbB2 itself has no known
89 ligand [22]. ErbB receptors are expressed by many cell types
90 and regulate diverse cellular functions that include prolifera-
91 tion, migration, cell fate decisions, differentiation and apop-
92 tosis [22,24]. In normal, undamaged skeletal muscle, erbB2,
93 erbB3 and erbB4 receptors are exclusively localised to the
94 neuromuscular junction (NMJ) [25,26], where they regulate the
95 expression of acetylcholine receptors [27,28] and glucose
96 transport within myofibres [29]. Although NRDc is highly
97 expressed by human skeletal muscle [30], its cellular localisa-
98 tion has not been determined. In tissue culture models of the
99 late phase of muscle injury, myoblasts express erbB1, erbB2
100 and erbB3 receptors [21,31–33], as they commit to differentia-
101 tion. However, it remains unknown whether erbB receptors
102 are expressed by satellite cells and if so, at which stage of the
103 activation process they first appear and how their expression
104 is regulated.
105 In this study, we show that satellite cells do not
106 express any erbB receptors in the quiescent state. How-
107 ever, erbB1, erbB2 and erbB3 become expressed within 6 h
108 of activation, while erbB4 and NRDc can be detected
109 within 24 h. We demonstrate that erbB2 signalling plays
110 an anti-apoptotic role in preserving the full complement
111 of satellite cells during this critical phase of stem cell
112 activation from quiescence.
1134 Materials and methods
115 Animals
116 C57Bl/10 mice, myosin light chain 3F-nLacZ-2E (MLC-3FnLacZ)
117 mice [34] and Myf5nLacZ/+ mice [35], aged between 6 and
118 8 weeks, were from breeding colonies maintained at MRC
119 Hammersmith.
120 Tissue preparation and single myofibre isolation
121 Entire extensor digitorum longus (EDL) and tibialis anterior (TA)
122 muscles were removed. The TAs were snap frozen for
123cryosectioning and the EDLs were dissociated into single
124muscle fibres (myofibres), as described previously [36].
125Myofibre culture
126Isolated myofibres were maintained as non-adherent cul-
127tures in DMEM, containing 10% horse serum (PAA Labora-
128tories) and 0.5% chick embryo extract (ICN Flow) as
129described previously [36]. Myofibres were subsequently
130fixed with 4% paraformaldehyde in PBS (4% PAF) for
13120 min prior to immunostaining.
132Growth factors
133Recombinant Human EGF, HB-EGF and NRG (NRG-1 β1 EGF
134domain) were obtained from R&D Systems.
135ErbB inhibitors
136The erbB1-selective inhibitor AG1478 (Calbiochem) was
137dissolved in DMSO and used at a 1:500 dilution to give a
13810-μM working concentration (autophosphorylation: erbB1
139IC50=0.003μM; erbB2 IC50>100 μM [37]). The erbB2-selective
140inhibitor AG825 (Calbiochem) was dissolved in DMSO and
141used at a 1:500 dilution to give a 50-μM working
142concentration (autophosphorylation: erbB2 IC50=0.35 μM;
143erbB1 IC50=19 μM. Substrate phosphorylation: erbB2 IC50=
1449.5 μM; erbB1 IC50>100 μM [38]). Control cultures contained
1451:500 DMSO.
146Signal transduction pathway-specific inhibitors
147All inhibitors were obtained from Calbiochem and were
148dissolved in DMSO, unless stated otherwise. The following
149inhibitors were used at the working concentrations shown
150(typically 1000-fold dilutions of the stock solution): Akt inhi-
151bitor, 10 μM (Akt IC50=5 μM). U0126, MEK1/2 inhibitor, 12.5 μM
152(MEK1 IC50=72 nM, MEK2 IC50=58 nM). Jnk inhibitor II, 20 μM
153(Jnk-1/Jnk-2 IC50=40 nM, Jnk-3 IC50=90 nM). SB203580,
154p38MAP-K inhibitor, 2 μM (p38MAP-K IC50= 600 nM). U-73122,
155PLCγ inhibitor, 5 μM (PLC IC50=2 μM). IC50 values are quoted
156from the product data sheets. Caspase-8 competitive inhibitor
157I, cell-permeable, 100 nM [39]. STAT3 inhibitor, cell-permeable,
1581 mM (solid dissolved directly in culture medium to working
159concentration, immediately prior to use) [40].
160Histology
161Cultured myofibres from MLC-3FnLacZ mice and TA muscle
162cryosections from Myf5nLacZ/+ mice were fixed in 4% PAF for
1635min. β-Galactosidase activitywas visualised by incubation in
1644 mM potassium ferrocyanide, 4 mM potassium ferricyanide,
1652 mM MgCl2, 400 μg/ml X-gal, 0.02% NP40 in PBS for 10 min at
16637°C. Myofibres were then washed in PBS and processed for
167immunohistochemistry.
168Immunostaining
169Fixed myofibres were permeabilised with 0.5% Triton X-100/
170PBS for 10 min. Cryosections were fixed in 4% PAF for 10 min
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171 and washed in PBS. Non-specific antibody binding was
172 blocked by incubation in 20% goat serum in PBS for 30 min.
173 Rabbit anti-erbB2 (sc-284, Santa Cruz, 1:200 dilution,
174 1 μg/ml working conc.) and rabbit anti-erbB4 (06-572,
175 Upstate, 1:100, 10 μg/ml working conc.) antibodies have
176 been previously characterised on rodent skeletal muscle
177 sections [26], while mouse anti-erbB3 antibody (Ab-5,
178 Calbiochem, 1:100, 2 μg/ml working conc.) has been
179 previously characterised on L6 and C2C12 rodent skeletal
180 muscle cell lines [33]. Other primary antibodies were mouse
181 anti-erbB1 (clone 13, BD Bioscience, 1:20, 12.5 μg/ml working
182 concentration); mouse anti-Pax7 (Developmental Studies
183 Hybridoma Bank, 1:10); rabbit anti-MyoD (sc-760, Santa
184 Cruz, 1:80); mouse anti-MyoD1 (clone 5.8A, DakoCytoma-
185 tion, 1:80); mouse anti-myogenin (clone F5D, Developmental
186 Studies Hybridoma Bank, 1:80); rabbit anti-NRDc (gift of
187 Annik Prat, Institut de Recherches Cliniques de Montreal,
188 1:400); rat anti-BrdU (Abcam, 1:500, used as in [10]); rabbit
189 anti-phospho(Tyr877)-erbB2 and rabbit anti-phospho
190 (Tyr1248)-erbB2 (Cell Signalling Technology, used together
191 at 1:50); rabbit anti-phospho(Tyr1173)-erbB1 (ab5652, Abcam,
192 1:100). Control mouse and rabbit IgG were used in place of
193 primary antibodies at 10 μg/ml.
194 Primary antibodies were applied overnight at 4°C and
195 then visualised by 2 h incubation with Alexa Fluor-con-
196 jugated secondary antibodies (Molecular Probes, 1:200).
197 Where indicated, Texas Red-conjugated α-bungarotoxin
198 (Molecular probes, 1:1000) was mixed with the secondary
199 antibody.
200 Immunostaining with antibodies against phosphorylated
201 erbBs was carried out as above, except all solutions contained
202 100 mM sodium orthovanadate. For de-phosphorylation
203 controls, permeabilised myofibres were incubated with 6 U/
204 ml alkaline phosphatase (Promega) in PBS pH8, without
205 orthovanadate, for 2 h at 37°C before proceeding with serum
206 blocking and primary antibodies.
207 Myofibres were mounted in Faramount (DakoCytomation)
208 containing either 100 ng/ml 1,4-diazobicyclo[2,2,2]octane
209 (DAPI) or 10 μg/ml propidium iodide. Conventional epifluor-
210 escence microscopy was performed with a Zeiss Axiophot
211 microscope. Images were captured with a CCD-1300-Y camera
212 (Princeton Instruments) and processed with Metamorph soft-
213 ware (4.5r5 Universal Imaging). Confocal microscopy was
214 performed with a Leica TCS-NT confocal microscope, using a
215 Leica PL APO 100×/1.40-0.70 oil-immersion objective. Optical
216 sections were recorded in 0.4 μm increments using sequential
217 capture of double immunostains.
218 Caspase assay
219 Cultured myofibres were fixed in 4% PAF for 5 min and
220 permeabilised for 10 min with 0.1% CHAPS and 2 mM EDTA
221 in Ca2+/Mg2+-free PBS.Myofibreswerewashed in 2mMEDTA in
222 Ca2+/Mg2+-free PBS and then incubated with 0.25 mM fluoro-
223 genic caspase-8 substrate: rhodamine 110, bis-(N-CBZ-L-iso-
224 leucyl-L-glutamyl-L-threonyl-L-aspartic acid amide) (Molecular
225 Probes) in 2mM EDTA in Ca2+/Mg2+-free PBS for 30min at 37°C.
226 Myofibres were washed in 0.025% Tween20 in PBS, mounted
227 without coverslip in 20% glycerol and viewed immediately on
228 an epifluorescence microscope using a fluorescein filter set.
229Myofibres were subsequently processed for Pax7 or MyoD
230immunofluorescence.
231TUNEL assay
232Cultured myofibres were fixed in 4% PAF for 30 min, washed
233in PBS and then processed with TACS TdT fluorescein
234according to the manufacturer's protocols (R&D Systems).
235Stained myofibres were subsequently processed for Pax7
236immunofluorescence.
237Cell counting and statistics
238The numbers of immunopositive cells per myofibre were
239counted by varying the focal plane at each point along the
240myofibre and are shown as the mean value ±SEM. Statistical
241differences between pairs of samples were assessed by
242unpaired 2-tailed Student's t-test. Statistical differences
243between multiple samples were assessed by Kruskal–Wallis
244non-parametric ANOVA with Dunn's post-test (GraphPad
245InStat 3.0a software).
2467Results
248Localisation of erbB receptors in uninjured skeletal muscle
249In sections of C57Bl/10 TA muscles, strong erbB1 immunor-
250eactivitywasobservedat theneuromuscular junction (NMJ, Fig.
2511A), identified by co-staining with α-bungarotoxin (Fig. 1A′).
252ErbB1 was also present generally on the surface of muscle
253fibres, connective tissue and capillaries (arrowhead and
254arrow, respectively in Fig. 1A). In agreement with previous
255studies [25,26] erbB2, erbB3 and erbB4 receptors were detected
256at the NMJ (Figs. 1B–D′). ErbB2 and erbB3 were additionally
257present on vasculature and connective tissues (Figs. 1B, C), in
258agreement with a previous study in rat [41]. Only erbB4 was
259present exclusively at NMJs (Fig. 1D′). NRDc was also localised
260predominantly to the NMJ (Fig. 1E′). However, towards the
261centre of the NMJ, NRDc immunostaining extended deep to
262the myofibre by an estimated 3–4 μm (arrowhead in Fig. 1E′).
263In addition, a subset of muscle fibres exhibited uniform NRDc
264immunoreactivity (asterisks in Fig. 1E), perhaps indicating
265differential expression in particular fibre types. In order to
266determine whether quiescent satellite cells expressed any
267erbB receptors, we used cryosections of EDL muscles from the
268Myf5nLacZ/+ transgenic mouse, in which β-galactosidase is
269expressed by quiescent satellite cells [42]. Staining with X-gal
270identified satellite cell nuclei (blue dye reaction product
271marked with arrowheads in Figs. 1H–N). Co-immunofluores-
272cence staining revealed that none of the receptors were de-
273tectable on quiescent satellite cells (Figs. 1H′–L′). DAPI
274staining confirmed the location of satellite cell nuclei,
275although DAPI fluorescence is masked where the X-gal reac-
276tion product is particularly intense at the thickest, central
277region of the nucleus (merged antibody/DAPI shown in Figs.
2781H″–L″). Importantly, DAPI can still be detected in a ring at
279the periphery of the nucleus. Thus, X-gal does not mask any
280fluorescence from the satellite cell cytoplasm or cell surface,
281where erbB receptors would be located.
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282 Localisation of erbB receptors during activation of satellite cells
283 Isolated EDL myofibre preparations, free of connective tissue,
284 capillaries and other non-muscle cells were maintained in
285 10% serum-containing medium for between 6 and 48 h.
286 During this period, the satellite cells associated with each
287 myofibre become activated (by the criterion of MyoD expres-
288 sion) and at around 24 h enter into vigorous cell division with
289 a resultant rapid amplification of their myogenic progeny
290 [4,42].
291 During the earliest stages of activation from quiescence
292 (within the first 6 h), neitherMyoD immunoreactivity norMyf5
293 expression accurately identify all satellite cells [4,42]. There-
294 fore, to investigate erbB receptor distribution on satellite cells
295 at 6 h in vitro (T6), we used EDL myofibres isolated from the
296 MLC-3FnLacZ transgenic mouse, in which β-galactosidase is
297 expressed exclusively by differentiated myonuclei. This
298approach allows the identification of all of the associated
299satellite cells, as they do not express the transgene and
300therefore fail to stain with X-gal [42] (Figs. 2A–Gʺ. Note that in
301those cells expressing β-galactosidase the intensely coloured
302X-gal reaction product masks the underlying DAPI nuclear
303fluorescence.) Typically, about 8 satellite cells are associated
304with each EDLmyofibre [4]. At T6, erbB1was detectable on 1.8±
3050.4 satellite cells permyofibre; about onequarter of the satellite
306cell population (23/92 of the X-gal-negative cells on 13 fibres ±
307SEM, Figs. 2A–A‴). ErbB2 was detectable on all satellite cells,
308with 4.4±0.5 satellite cells per myofibre (about half the
309population) being strongly immunofluorescent (84/165 of the
310X-gal-negative cells on 19 fibres ±SEM; strongly erbB2 immu-
311nofluorescent cell arrowed; Fig. 2Bʺ). ErbB3 was only weakly
312detected and was present on 1.4±0.4 satellite cells per
313myofibre; about 15% of the population (20/132 of the X-gal-
314negative cells on 14 fibres ±SEM, Fig. 2C). By contrast, erbB4
Fig. 1 – ErbB receptor distribution on undamaged panel muscles. (A–G V) C57Bl/10 TA muscle transverse sections were dual
stained with receptor-specific antibodies (green in merged images) and α-bungarotoxin to label the NMJ (BTX, red in merged
images). Host species of primary antibody is denoted bymouse (m) or rabbit (r) in parenthesis after the antibody name. ErbB1 is
present on myofibre surfaces (arrowhead in panel A) and on interstitial tissues and capillaries (arrow in A). (E, E V) NRDc is
occasionally present deep to the NMJ (arrowhead in panel E V) and identifies a subset of myofibres (asterisks in E). (H–NW)
Myf5nLacZ/+ TA muscle transverse sections, triple labelled with (H–N) X-gal to identify Myf5+ satellite cell nuclei; (H V–L V)
receptor-specific antibodies; and (HW–NW) merged antibody and DAPI nuclear stain images. Satellite cell nuclei aremarkedwith
an arrowhead in each series of images. (F, M V) Ctrl(m) and (G, N V) Ctrl(r) are, respectively, mouse and rabbit IgG controls
photographed under identical conditions. Scale bars are 50 μm. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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315 (Fig. 2D) and NRDc (Fig. 2E) were not detected (compare with
316 serum controls in Figs. 2F, G).
317 After 24 h in vitro, virtually all myofibre-associated satellite
318 cells can be identified by the expression of MyoD [4]. Thus, for
319 experiments at 24 h and later we used EDL myofibres isolated
320 from C57Bl/10 mice, dual stained with MyoD and erbB
321 receptor-specific antibodies.
322 After 24 h in vitro (T24), erbB1 was detectable on all MyoD+
323 satellite cells, with intense immunofluorescence observed on
324 2.9±0.5 satellite cells per myofibre (41/82 MyoD+ cells on 14
325 fibres ±SEM, compare the intensities of the two satellite cells
326 arrowed in Fig. 2H). All other receptor antibodies demon-
327 strated a uniformity of robust immunofluorescence labelling
328 throughout the MyoD+ satellite cell population. Some MyoD-
329 myonuclei demonstrated weak immunoreactivity with anti-
330 NRDc at T24 (Fig. 2L). Confocal microscopy of T24 myofibres,
331dual stained with individual anti-erbB antibodies and the
332nuclear marker propidium iodide, confirmed the surface/
333cytoplasmic location of erbB1-4 (Figs. 3A–D). Moreover, both
334confocal microscopy (Figs. 3E, F, O) and conventional epifluor-
335escence microscopy (Figs. 3G–J, K–N, P–S) revealed co-localisa-
336tion of erbB1/erbB2, erbB2/erbB3 and erbB3/erbB4 in activated
337satellite cells.
338After 48 h in vitro (T48), all myoblasts on isolated mouse
339EDL myofibres had become strongly immunoreactive for
340erbB1, erbB2, erbB4 and NRDc, while erbB3 was now only
341weakly detected (Figs. 4A–E V). After 48 h, myoblasts on isolated
342myofibres diversify with respect to MyoD expression: a
343minority reduce their levels of MyoD and return to an
344undifferentiated quiescent state, while the majority maintain
345MyoD and eventually express myogenin as they enter
346terminal differentiation [10]. Importantly, we found that the
Fig. 2 – Following injury, erbB receptors become localised to activating satellite cells. Isolated EDL myofibres immunostained
with receptor-specific antibodies (green inmerged images) andDAPI (blue) following6or 24h in 10%serum-containingmedium.
Host species of primary antibody is denoted by mouse (m) or rabbit (r) in parenthesis after the antibody name. (A–GW) 6 h:
MLC-3FnLacZ transgenicmyofibres, inwhichmyonuclei stain darklywithX-gal. (A–AW) Approximately 25%of satellite cells show
erbB1 immunoreactivity (compare the two arrowed satellite cells). (B–BW) All satellite cells are erbB2 immunopositive,with about
half showing strong immunoreactivity (arrowed in BW). (H–NW) 24 h: Myofibres from C57Bl/10 mice. MyoD is red in merged
images. (H–H V) ErbB1 immunoreactivity showed variationswithin the satellite cell population (compare the two cells arrowed in
H). (F,M) Ctrl(m) and (G, N) Ctrl(r) are, respectively,mouse and rabbit IgG controls photographed under identical conditions. Scale
bar is 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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347 immunofluorescence intensity of erbB receptor and NRDc
348 staining on satellite cells at T48 was equivalent across the
349 entire population, irrespective of variations in MyoD immu-
350noreactivity (in Figs. 4C″, H′, I′ myoblasts showing reduced
351MyoD staining aremarkedwith arrowheads). However, by T72,
352the immunofluorescence intensity of erbB2 on isolated EDL
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353 myofibres did exhibit variation within the myoblast popula-
354 tion (Fig. 4J), being more intense on cells that had committed
355 to differentiation and were co-expressing myogenin (Fig. 4J′).
356 Not all satellite cells have active erbB receptors
357 To begin to address what functions erbB receptors might play
358 during satellite cell activation, we first determined if the
359 receptors are functional. ErbB ligand growth factors are
360 present in normal serum [43–45] and should therefore be
361 freely available in our culture medium. EDLmyofibre prepara-
362 tions were maintained in vitro for 24 h and then immunos-
363 tained with antibodies specific to phosphorylated (active)
364forms of erbB1 and erbB2. On average, 4.5±1.1 cells per
365myofibre (n=11 fibres) were immunopositive for phosphory-
366lated erbB1 (Figs. 5A, B) and 2.7±0.5 cells per fibre (n=10 fibres)
367were immunopositive for phosphorylated erbB2 (Figs. 5E, F).
368The average number of satellite cells on each of these
369myofibres was determined to be 6.8±0.5 by subsequent Pax7
370immunostaining (not shown). As expected, when T24 cultured
371myofibres were treated with alkaline phosphatase, prior to
372immunostaining with anti-phosphorylated erbBs, no immu-
373nopositive cells were detected (erbB1 control, Figs. 5C, D; erbB2
374control, Figs. 5G, H), confirming that these antibodies recog-
375nise only the phosphorylated forms of the receptors. Because
376erbB1 and erbB2 receptors are exclusively detected on all
Fig. 3 – (A–D) Confocal images of C57Bl/10 isolated EDLmyofibres after 24 h in 10% serum containingmedium, immunostained
with erbB receptor-specific antibodies (green channel) and propidium iodide nuclear marker (PI, red channel). (E, F, O)
Co-expression of erbB receptors on satellite cells at T24. Each confocal image is a field 100 μm×100 μm square. The z-axis
depth of each confocal image in marked in the bottom right corner. (G–N, P–S) Corresponding epifluorescence images of double
immunostained myofibres, plus DAPI nuclear stain. Scale bars in epifluorescence images are 50 μm.
Fig. 4 – Isolated EDL myofibres immunostained following (A–I′) 48 h or (J–J′) 72 h in 10% serum-containing medium with
receptor-specific antibodies (green inmerged images). Host species of primary antibody is denoted bymouse (m) or rabbit (r) in
parenthesis after the antibody name. Arrowheads in (H″, I′ and C′) show a subpopulation of myoblasts labelled with receptor
antibodies even when MyoD (red in merged images) is down-regulated. (J–J′) 72 h: ErbB2 immunoreactivity in green and
myogenin immunoreactivity in red. (F) Ctrl(m) and (G) Ctrl(r) are, respectively, mouse and rabbit IgG controls photographed
under identical conditions. Scale bar is 50 μm. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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377 satellite cells by T24 (Fig. 2), this implies that at any one time
378 only about 66% of satellite cells are stimulated via erbB1 and
379 39% via erbB2 signalling pathways. No pattern was detected in
380 the distribution of these “stimulated” satellite cells along
381 myofibres. In order to help determine whether erbB1 and
382 erbB2 are active in the same cells, we sequentially immunos-
383 tained T24 myofibres with anti-phospho erbB1 then Alexa 488
384 secondary antibody, followed by anti-phospho erbB2 then
385 Alexa 594 secondary antibody. Some T24 myofibres were
386 stained in the opposite sequence, i.e., anti-phospho erbB2 was
387 applied first (Figs. 5I–T). We found that 12.9% of labelled cells
388 (4/31 cells on 9 myofibres) labelled exclusively with anti-
389 phospho erbB1 when this was the final layer (compare Figs. 5L
390 and M), while 3.2% of labelled cells (2/63 cells on 16 myofibres)
391 were exclusively anti-phospho erbB2 immunopositive when
392 this was the final layer (compare Figs. 5R and S). Thus, the
393remaining 83.9% of anti-phospho erbB immunostained cells
394contain both erbB1 and erbB2 in their phosphorylated forms,
395corresponding to about three cells per fibre in this experiment.
396ErbB ligand growth factors prevent early myoblast cell death
397To investigate the consequences of erbB ligand withdrawal,
398EDL-isolated myofibre preparations were maintained in 10%
399serum-containing medium for 24 h, to allow up-regulation of
400erbB receptors on the satellite cells. At this point, the
401preparations were separated into different culture conditions
402for a further 24 h (between T24 and T48). Some continued to be
403maintained in 10% serummedium, while others were washed
404in DMEM and transferred into serum-free DMEM and supple-
405mentedwith either: nothing, 1 nM EGF (erbB1 ligand), 1 nMHB-
406EGF (erbB1,4 and NRDc ligand), 1 nM neuregulin (NRG) (erbB3,4
407ligand) or a 1-nM mixture of all three erbB ligand growth
408factors. Immunostaining confirmed that all erbB receptors and
409NRDcwere still present onmyoblasts in preparations deprived
410of serum between T24 and T48, although the immunofluores-
411cence intensity for erbB1 was reduced (not shown).
412As expected, there was a significant difference (P<0.001)
413between the numbers of Pax7+ cells per fibre when comparing
414serum-maintained with unsupplemented serum-free condi-
415tions (compare Figs. 6A and D). Importantly, however, this
416was not simply attributable to differences in proliferation,
417since the numbers of Pax7+ cells associated with serum-de-
418prived myofibres was significantly below (P<0.01) their star-
419ting value on T0 myofibres (Fig. 6G). Supplementation with
4201 nM NRG or 1 nM EGF alone similarly resulted in a significant
421loss of Pax7+ cells compared to T0 (P<0.01 and P<0.001, res-
422pectively; Fig. 6G). By contrast, supplementing serum-free
423medium with 1 nM HB-EGF or a 1-nM mixture of all three
424growth factors prevented the loss of Pax7+ cells compared
425with T0 (Fig. 6G).
426A similar trend was seen with MyoD immunoreactivity.
427Thus, serum-deprived myofibres were associated with sig-
428nificantly fewer MyoD+ cells than serum-maintained controls
429(P<0.001; compare Figs. 6B and E). Supplementing serum-free
430cultures with a 1-nM mixture of growth factors resulted in a
431significant increase in the number of MyoD+ cells per fibre
432compared to serum-free controls (P<0.001; Fig. 6G). However,
433serum-free cultures supplementedwith 1 nMNRG or 1 nM EGF
434had significantly fewer MyoD+ cells per myofibre than
435cultures supplemented with the growth factor mixture
436(P<0.001 and P<0.01, respectively, in Fig. 6G). The number of
437MyoD+ cells per fibre was statistically indistinguishable
438between growth factor mixture-supplemented and HB-EGF-
439supplemented myofibres (Fig. 6G). Although the growth factor
440mixture increased the number of MyoD+ cells compared to
441DMEM, or NRG or EGF, it was not as efficient as 10% serum in
442generating large numbers of MyoD+ cells (P<0.05; Fig. 6G).
443Toassess the role of erbB3activity in promoting satellite cell
444survival, a function-blocking concentration of anti-erbB3 anti-
445body (10 μg/ml [46]) was added to serum-maintained myofibre
446cultures between T24 and T48. Anti-erbB3 had no effect on the
447numbers of Caspase8+ cells per myofibre (control: 4.25±0.7,
448n=12 myofibres; anti-erbB3: 4.29±0.6, n=14 myofibres) but
449did significantly (P=0.013) reduce the number of MyoD+ cells
450per myofibre from 14.1±1.0 (n=15 myofibres) to 10.0±1.2
Fig. 5 – (A–H) EDL isolated myofibres cultured for 24 h and
immunostained with antibodies specific to (A–D)
phosphorylated erbB1 and (E–H) phosphorylated erbB2. (C, D,
G, H) Myofibres pre-treated with alkaline phosphatase
confirmed the specificity of the antibodies for the
phosphorylated forms of the receptors. (I–T) Sequential
immunostainingwith the anti-phospho antibodies identified
cells that contained a mixture of phosphorylated erbB1 and
phosphorylated erbB2 (I–K and O–Q), but also cells that had
exclusively either (M) phosphorylated erbB1 or (S)
phosphorylated erbB2. DAPI counterstaining (blue) identifies
cell nuclei. ″=phosphorylated. Scale bar is 50 μm. (For
interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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451 (n=18myofibres). Any effects of anti-erbB3 on cell proliferation
452 were not assessed.
453 As myoblasts withdraw from the cell cycle as a prelude to
454 terminal differentiation, they begin to express myogenin and
455 subsequently down-regulate MyoD. However, differentiation
456cannot account for the lower numbers of MyoD+ cells upon
457serum withdrawal. Differentiation was apparent in the pre-
458parations maintained from T24 to T48 in serum-free condi-
459tions, since 94.4% (51/54) of MyoD+ cells co-expressed
460myogenin (Fig. 6H). In contrast, no myogenin+ cells (0/162)
Fig. 6 – ErbB ligand growth factors protect myoblasts from apoptosis. (A–F) Myofibres weremaintained in the absence of serum
between T24 and T48 and stained for Pax7 (red), MyoD (green) and DAPI (blue). Some cells are returning to quiescence
(Pax7+/MyoD− cell identified with arrowhead) and others are differentiating (Pax7−/MyoD+ cell identified with arrow). (G)
Comparisons of the mean numbers of Pax7+ and MyoD+ cells per myofibre, on myofibres maintained either in serum, or in
serum-free conditions (with or without individual growth factors or a mixture of growth factors). T0 Pax7 indicates the mean
number of Pax7+ cells on T0 myofibres. (H, I) Expression of myogenin (red) and MyoD (green) in serum-containing and in
serum-free conditions. The fluorescence channels corresponding to the boxed regions in the merged images are shown as
separate insets. (J) Many cells activated caspase-8 in serum-free conditions (arrows). (L) Caspase-8 activation was substantially
prevented by the mixture of growth factors (arrows), quantified in panel P. (M–O) corresponding phase contrast images.
(Q–S) The majority of apoptotic cells were MyoD+ (arrowheads in merged image S). A rare caspase8+/MyoD− exception is
arrowed in panel S (inset). DAPI counterstaining (blue) identifies cell nuclei. Scale bar is 100 μm for panels J–O. For all other
images, this bar is 50 μm. Statistical analyses: *P<0.05, **P<0.01, ***P<0.001, ns=not significant. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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461 were present on myofibres maintained in 10% serum (Fig. 6I).
462 Growth factor supplementation had no effect on the propor-
463 tion of differentiating cells compared to serum-deprived
464 myofibres (1 nM EGF: 92.1% (82 myogenin+/89 MyoD+); 1 nM
465 HB-EGF: 89.8% (53/59); 1 nM NRG: 95.7% (44/46); or a 1-nM
466 growth factor mixture: 97.2% (69/71)). Crucially, no MyoD−/
467 myogenin+ cells were detected on serum-deprived myofibres.
468 This is important because it shows that upon serum depriva-
469 tion, all the differentiating myogenin+ cells continue to
470 express MyoD. Therefore, the observed reduction in the
471 number of MyoD+ cells must indeed represent a true absence
472 of these cells and not simply a differentiation-induced change
473 of phenotype. An alternative explanation for the loss of
474 MyoD+ cells might be that serum-deprived myoblasts return
475 to their Pax7+/MyoD-quiescent state. However, since the
476 number of Pax7+ cells is also reduced, to significantly less
477 than the T0 value, a return to quiescence can be discounted.
478 To determine whether apoptotic cell death might account
479 for the loss of MyoD+ cells upon serum deprivation, we
480 assayedmyofibre preparations for the activation of caspase-8.
481 Caspase-8 was chosen because it is activated very early during
482 apoptosis, being a critical initiator of the death receptor
483 pathway [47], but additionally regulating the mitochondrial
484 pathway by promoting the activation of Bax and Bak [48].
485 Furthermore, caspase-8 is activated by singlet oxygen ROS,
486 upstream of caspase-3 activation [49]. In the absence of serum
487 between T24 and T48, six-fold more cells on myofibres
488 activated caspase-8 than in serum-containing control condi-
489 tions (compare Figs. 6J, M with Figs. 6K, N; quantified in Fig.
490 6P). The majority of apoptosing caspase-8+ cells on T24–T48
491 serum-deprived myofibres were also MyoD+ (73.7%, 14/19
492 cells; Fig. 6S). Conversely, and in agreement with the Pax7/
493 MyoD immunoreactivity data of Fig. 6G, serum-deprived
494 myofibre preparations supplemented with a 1-nM mixture of
495 growth factors demonstrated significantly less caspase-8
496 activation than serum-deprived controls (P<0.05; Figs. 6L, O,
497 P). Serum-deprived preparations supplemented with 1 nM EGF
498 or 1 nM HB-EGF, but not 1 nM NRG alone, also demonstrated
499 reduced caspase-8 activation (Fig. 6P). Although it is clear that
500 apoptosis is initiated in MyoD+ myoblasts in response to
501 serum deprivation (Figs. 6J–S), because caspase-8 activity was
502 only assayed at T48, we cannot formally conclude that
503 apoptosis is the only mechanism by which myoblasts are
504 lost during the T24–T48 period of serum deprivation.
505 Taken together, these data suggest that a mixture of erbB1/
506 erbB4 ligands (EGF and HB-EGF) but not an erbB3/erbB4 ligand
507 (NRG) act to protect activated satellite cells and their myoblast
508 progeny from cell death.
509 Inhibition of erbB2 signalling promotes myoblast apoptosis
510 ErbB1 is the common receptor bound by EGF and HB-EGF,
511 although subsequent signal transduction can occur either via
512 erbB1 homodimers or via erbB1/erbB2 heterodimers [50,51]. To
513 determine whether inhibition of either erbB1 or erbB2 signal-
514 ling leads to satellite cell or myoblast apoptosis, we examined
515 caspase-8 activity in myofibre preparations cultured for 6 h,
516 24 h or 48 h in 10% serum-containing medium supplemented
517 with highly specific inhibitors of erbB1 or erbB2 tyrosine
518 phosphorylation: AG1478 and AG825, respectively [37] (Figs.
5197A–N). By T24, approximately two times more cells exhibited
520caspase-8 activity in the presence of AG825 (Figs. 7E, M)
521compared to either AG1478 (Fig. 7G, M) or unsupplemented
522controls (Figs. 7H, M). These preparations were subsequently
523immunostained, revealing that it was predominantly Pax7+
524satellite cells that were undergoing apoptosis (arrowheads in
525Figs. 7B′, F′, J′). Although AG825-induced caspase-8 activation
526peaked at T24 (Fig. 7M), it took a further 24 h for this initiation
527of cell death to be reflected in a significant depletion of Pax7+
528cells on AG825-treated myofibres (Fig. 7N). Thus, AG825
529resulted on average in a loss of one Pax7+ cell per fibre
530(∼15% of the satellite cell population) by T24, and four Pax7+
531cells per fibre by T48, compared to unsupplemented controls
532(Fig. 7N). The erbB inhibitors did not affect satellite cell
533activation or cell cycle progression. Thus, in separate experi-
534ments, Pax7+ satellite cells activated MyoD as normal in the
535presence of AG825 (T0–T24 AG825: 189 Pax7+/184 MyoD+,
536n=26 fibres. T0–T24 control: 284Pax7+/277 MyoD+, n=30
537fibres); while 95 of 96 Pax7+ cells incorporated BrdU (from 9
538fibres) during 48 h in the continuous presence of AG825
539plus BrdU.
540The loss of Pax7+ cells in the presence of AG825 appeared
541modest, although consistent with the values obtained from
542the serum-free growth factor supplementation experiments
543(Fig. 6G). To better model the oxidative stresses that myofibres
544are subjected to immediately following damage in vivo, we
545maintained myofibres in 10% serum-containing medium for
5466 h to allow erbB receptors to become up-regulated (see Fig. 2),
547and then supplemented half of the myofibre preparations
548with 100 μM hydrogen peroxide (H2O2), with or without erbB
549inhibitors, for a further 18 h until T24. This concentration of
550H2O2 was chosen because it is high enough to induce a stress
551response in myofibres but does not affect their viability [52].
552The presence of H2O2 in itself did not cause a significant loss of
553Pax7+ cells (Fig. 7O). Only in cultures co-supplemented with
554H2O2 and AG825 or AG1478 were there significant losses of
555Pax7+ cells (Fig. 7O).
556TUNEL provides a sensitive indicator of late-stage apopto-
557tic cells, after DNA fragmentation has occurred. Consistent
558with the caspase-8 results, exposure of myofibres to AG825 in
55910% serum-containing medium for 24 h led to an increase in
560the proportion of dual TUNEL+/Pax7+ cells per fibre (10.7±
5614.4%, n=10 fibres; Figs. 7P–R), compared to unsupplemented
562controls (4.6±2.1%, n=18 fibres; Figs. 7S–U).
563Pro- and anti-apoptotic signals in activating satellite cells
564Signal transduction via erbB receptors can activate several
565distinct intracellular signalling pathways that include phos-
566phatidylinositol 3′ kinase/protein kinase B (PI3-K/Akt), Ras/
567mitogen-activated protein kinase (Ras/MAP-K) and phospho-
568lipase Cγ/protein kinase C (PLCγ/PKC) [22,24]. In addition,
569erbB2 (via erbB1–erbB2 heterodimers) directly phosphorylates
570the transcription factor STAT3 [53]. Each of these erbB signal
571transduction pathways has been implicated in opposing
572survival and apoptosis decisions within a variety of cell-
573types, including muscle [54–57]. Therefore, in order to identify
574the pro-and anti-apoptotic signalling pathways operating in
575satellite cells during the first 24 h in culture, we examined the
576effects of inhibitors specific to these various pathways.
10 E X P E R I M E N T A L C E L L R E S E A R C H X X ( 2 0 0 6 ) X X X – X X X
ARTICLE IN PRESS
Please cite this article as: J.P. Golding, et al., Skeletal muscle stem cells express anti-apoptotic ErbB receptors during activation
from quiescence, Exp. Cell Res. (2006), doi:10.1016/j.yexcr.2006.10.019
UN
CO
RR
EC
TE
D
PR
OO
F
577 EDL myofibres, isolated from the same mouse, were
578 maintained for 24 h in 10% serum-containing medium in the
579 continuous presence of individual inhibitors, with or without
580 AG825, and were then assayed for caspase-8 activity, followed
581 by dual Pax7/MyoD immunostaining. The numbers of immu-
582 nopositive and caspase-8+ cells were counted on 15–20
583 myofibres per condition (Fig. 8A). This batch of myofibres
584 had more satellite cells per fibre and was twice as sensitive to
585 AG825 than the group used in Figs. 7A–N; with four-fold more
586 caspase-8+ cells per fibre and an average loss of two Pax7+
587 satellite cells per fibre following 24 h in AG825, compared with
588 untreated control myofibres (Fig. 8A).
589Inhibition of STAT3 resulted in a similar level of caspase-8
590activation to that seen following erbB2 inhibition. However,
591despite this high caspase-8 activity, satellite cell numbers
592were reduced by on average only one satellite cell per
593myofibre. Co-inhibition of STAT3 and erbB2 caused hypercon-
594traction of all fibres, precluding further analysis. These data
595indicate an anti-apoptotic role for the STAT3 pathway during
596satellite cell activation from quiescence (Fig. 8A).
597Inhibition of Akt resulted in an average loss of one satellite
598cell per fibre, although caspase-8 was not elevated; suggesting
599a slight protective, although not necessarily anti-apoptotic,
600role for Akt signalling (Fig. 8A).
Fig. 7 – Inhibition of erbB2 function leads to satellite cell and myoblast apoptosis. (A–L′) Mouse isolated EDL myofibres show
similar levels of caspase-8 activation following 6 h or 48 h exposure to AG825, AG1478 or control conditions. (E–H′) Following
24 h exposuremanymore cells demonstrate caspase-8 activation in (E) AG825, than in (G) AG1478, or (H) control conditions. (B′,
F′, J′) Double caspase-8/Pax7 immunostaining reveals that satellite cells are the predominant apoptosing cell type at each time
point (double-positive cells marked with arrowheads). (M) Graphical representation of the caspase-8 data, illustrating the peak
of AG825-induced apoptosis at T24. (N) Number of Pax7+ cells per myofibre in the presence of AG825 or AG1478, compared to
control. (O) Between T0 and T24, AG825 andAG1478 cause significant losses of Pax7+ satellite cells under conditions of elevated
oxidative stress (supplementation with 100 μM H2O2). (P–U) Double TUNEL/Pax7 immunostaining confirmed satellite cell
apoptosis following 24 h exposure to AG825 (P–R), but not in control conditions (S–U). Statistical analyses: *P<0.05, ***P<0.001.
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601 Conversely, inhibition of MEK resulted in a net gain of one
602 satellite cell per fibre compared with controls. Importantly, all
603 satellite cells counted following MEK inhibition were well-
604 isolated singlets, with no evidence of premature cell division
605 compared with the control preparations. Moreover, co-inhibi-
606 tionofMEKand erbB2partially rescued the loss of satellite cells
607 seen with erbB2 inhibition alone. This would suggest that the
608 Ras/MEK pathway has a net pro-apoptotic effect during
609 satellite cell activation, accounting for a background loss of
610 one satellite cell per fibre by T24 under our relatively benign
611 10% serum-containing medium culture conditions (Fig. 8A).
612 Inhibition of JNK or p38 MAP-K pathways had no effect on
613 satellite cell numbers, even though JNK inhibition caused a
614 slight increase in caspase-8 activation (Fig. 8A). Inhibition of
615 PLCγ/PKC caused myofibre hypercontraction within 24 h, pre-
616 venting any analysis of satellite cells under these conditions.
617 The control number of satellite cells per fibre was main-
618 tained following competitive inhibition of caspase-8. Dual
619 caspase-8/erbB2 co-inhibition partially prevented the loss of
620 satellite cells seen following erbB2 inhibition alone (2.7±0.4
621 versus 0.7±0.3 Pax7+ cells per fibre, n=16 fibres), confirming
622 that satellite cell death following erbB2 inhibition occurs via
623 caspase-8-mediated apoptosis (Fig. 8A).
624 Inhibition of MEK pro-apoptotic signals improves myoblast
625 survival
626 We found that by inhibiting Ras/MEK-mediated pro-apoptotic
627 signals in activating satellite cells under our relatively benign
628 culture conditions, we could protect on average one satellite
629 cell per myofibre from apoptosis (∼15% of the satellite cell
630 population) (Fig. 8A). We predicted that this modest improve-
631 ment in satellite cell survival should subsequently be reflected
632 in a proportionate increase in the number of amplifying
633 myoblast progeny. To confirm this, EDLmyofibre preparations
634 were maintained in 10% serum-containing medium in the
635 continuous presence of MEK inhibitor plus BrdU for 24 h,
636 during the period of satellite cell activation. The myofibres
637 were thenwashed andmaintained for a further 24 h (until T48)
638 in 10% serum without BrdU or inhibitor. To disassociate any
639 effects of proliferation from survival, some preparations were
640 fixed after the initial 24 h and anti-BrdU immunostaining
641 confirmed that MEK inhibition did not cause premature entry
642into the cell cycle (both control and MEK-treated myofibres
643had 1 BrdU+ cell per 10 myofibres). Pax7 immunostaining
644revealed that temporary inhibition ofMEK betweenT0 and T24
645significantly increased (P<0.05) the average number of myo-
646blasts per myofibre that survived to T48 (14 cells/fibre,
647n=19 fibres), compared to controls (10 cells/fibre, n=20 fibres;
648Fig. 8B). From our knowledge of satellite cell proliferation
649kinetics in vitro [4], two cell doublings should have occurred by
650T48. Thus, the extra fourmyoblasts per fibre is fully consistent
651with the protection of on average one satellite cell per
652myofibre during the activation phase.
6534Discussion
655Previous studies have reported that erbB2, erbB3 and erbB4
656receptors are expressed by normal adult skeletal muscles
657exclusively at the NMJ [25,26], while erbB1–erbB3 receptors
658have been detected on differentiating myoblasts in vitro
659[21,31–33]. However, the expression of erbB receptors by
660myogenic cells during the intervening period, at the onset of
661muscle regeneration, has hitherto not been explored. Here, we
662provide the first description that erbB1-4 receptor tyrosine
663kinases and NRDc co-receptor become expressed by satellite
664cells, the stem cell population of adult skeletal muscle, as they
665activate from quiescence. Signals transduced via erbB recep-
666tors control a diverse set of cellular functions, from growth,
667migration and differentiation, to survival and apoptosis [22].
668Within myoblasts, the functions attributed to erbB signalling
669include neuregulin/erbB3-mediated promotion of differentia-
670tion and fusion [33] and erbB2-dependent survival of differ-
671entiating myoblasts [21]. Specifically, erbB2 conditional
672knockout mice have been created, in which the muscle
673creatine kinase promoter (MCK) drives Cre-mediated excision
674of floxed erbB2 exclusively in heart and skeletal muscles [21].
675These erbB2-deficient mice exhibit extensive myoblast apop-
676tosis during differentiation [21]. However, MCK is not
677expressed by undifferentiated satellite cells [58] and only
678becomes expressed during myoblast differentiation [21], so
679the role of erbB2 during the early stages of muscle regenera-
680tion could not be assessed in that model.
681Using the isolated myofibre culture system, an in vitro
682model of satellite cell activation, we have found that although
Fig. 8 – (A) Myofibres were exposed to a variety of signal transduction pathway inhibitors for 24 h, in the absence or presence of
the erbB2 inhibitor AG825 (inhibited pathways indicated on x-axis). The number of caspase-8+, Pax7+ and MyoD+ cells per
myofibre were quantified for each condition. (B) Effect of transient inhibition of MEK (between T0 and T24) on the numbers of
Pax7+ cells per myofibre at T48. Statistical analyses: *P<0.05.
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683 absent during quiescence, erbB receptors can be detected on
684 satellite cells after 6 h of culture under activating conditions.
685 This iswell before cell division occurs in thismodel system [10]
686 and so erbB signalling cannot play a significant role in cell
687 proliferationor differentiationat this stage. Instead, our results
688 suggest that signalling via erbB2, and to a lesser extent via
689 erbB1, provides an anti-apoptotic survival mechanism for
690 satellite cells undergoing activation; a process that normally
691 occurs in the context of a damaged, degenerating muscle
692 environment. Sequential staining experiments indicate that
693 erbB1 and erbB2 are phosphorylated co-ordinately in >80% of
694 satellite cells at T24, although thismaynotnecessarily be in the
695 form of erbB1/erbB2 heterodimers. It is unclear what functions
696 erbB3anderbB4might serve inactivatedsatellite cells. Canto et
697 al. [29,59] show that erbB3 and erbB4 signalling are important
698 for glucose transport in skeletal muscle, although it is not
699 known whether satellite cells are involved. We found that
700 inhibition of erbB3 between T24 and T48 did not promote
701 caspase-8-mediated apoptosis, although thenumber ofMyoD+
702 cells was lower than controls, suggesting a possible role in
703 promoting cell proliferation or a return to quiescence. The role
704 of erbB4 signalling is not explored directly in this paper. ErbB4
705 is detectable fromT24 onwards on satellite cells and it could be
706 operating in the formof erbB4/erbB2 heterodimers. However, it
707 is clear that NRG, an important erbB4 ligand, is insufficient by
708 itself to promote satellite cell survival even though it was used
709 at a concentration (71 ng/ml) that should maximise receptor
710 stimulation (ED50 0.5–2.0 ng/ml, R&D Systems data sheet).
711 In serum-free conditions, a mixture of three erbB ligands
712 (NRG, EGF and HB-EGF) was found to reduce caspase-8
713 activation in myoblasts and to help preserve myoblast cell
714 numbers, although it remains to be proven if this link is
715 causal. These erbB ligands were specifically chosen because
716 they are produced by skeletal muscle [60–62], and it is
717 therefore likely that these growth factors would be readily
718 available to satellite cells following myotrauma. Despite the
719 likely availability of erbB ligand growth factors, only a
720 subpopulation of satellite cells were found to be using erbB1
721 or erbB2 signalling at any one time during activation. Thus, by
722 T24, about 3 satellite cells per myofibre robustly express erbB1
723 and have the receptor in a phosphorylated state; while all
724 satellite cells express erbB2 by T24, although only about 2
725 satellite cells per myofibre have erbB2 in a phosphorylated
726 state. These values are consistent with our observation that
727 between T0 and T24 about one satellite cell per myofibre
728 (∼15% of the quiescent population) is protected from apopto-
729 sis by erbB2 signalling. In the presence of increased oxidative
730 stress (100 μM H2O2), a closer analogy to in vivo myotrauma
731 and ischemia-reperfusion injuries [12–14,19,63], an additional
732 two satellite cells per myofibre (∼45% of the population) are
733 protected from cell death by erbB2 signalling.
734 In a variety of cell types, ROS stimulates erbB1 phosphory-
735 lation [64,65], and because erbB1 activation can transactivate
736 erbB2 [22,66,67], it follows that those satellite cells under the
737 greatest pro-apoptotic stress should exhibit thehighest activity
738 of erbB1/erbB2. If the anti-apoptotic signals are removed, by
739 inhibiting erbB2 phosphorylation using AG825, then these cells
740 become overwhelmed by pro-apoptotic signals and die.
741 The pro-apoptotic and anti-apoptotic mechanisms that
742 operate in activating satellite cells are most likely complex
743and interactive. Nevertheless, erbB signalling modules are
744well placed to be important master regulators of these
745signalling networks. Thus, erbB receptor signalling directly
746activates Ras/Raf/MAP-K, PI3-K/Akt, PLCγ/PKC and STAT
747signal transduction pathways. All of these root pathways
748can subsequently affect the survival/apoptosis balance of the
749cell, although the details are cell-type dependent and some-
750times contradictory [54]. Moreover, the apoptotic process can
751feed back on erbB signalling, since several caspases cleave
752erbB1 and erbB2 [54,68].
753Our data indicate an anti-apoptotic role for STAT3 within
754activating satellite cells. STAT3 becomes potently activated in
755satellite cells within 3 h of myotrauma [69] and induces the
756transcription of anti-apoptotic Bcl-2/x and caspase inhibitors
757[54], the latter being consistent with our observation of a large
758increase in caspase-8 activation following STAT3 inhibition.
759Because erbB1–erbB2 heterodimers directly phosphorylate
760STAT3 [53], any erbB1/2 signalling is likely to provide a crucial
761source of phosphorylated STAT3 to helpmaintain the viability
762of a stressed satellite cell.
763Conversely, our data suggest a pro-apoptotic role for MEK
764within activating satellite cells. Little is known concerning the
765role of MEK in apoptosis, although interestingly one report
766demonstrates that inhibition of MEK1,2 prevents apoptosis in
767a lung cancer cell line [70]. We find that inhibition of MEK1,2
768phosphorylation preserves on average one satellite cell per
769myofibre, subsequently resulting in a proportionate increase
770in the numbers of proliferating myoblast progeny. Co-inhibi-
771tion of MEK and erbB2 prevents the loss of satellite cells
772normally seen with erbB2 inhibition alone. The different
773outcomes of MEK inhibition and MEK/erbB2 dual-inhibition
774would be consistent with amodel whereby erbB2 signals act to
775prevent apoptosis initiation, while MEK signals promote
776apoptosis execution. Although our data suggests direct
777intracellular links between erbB1/2 signalling and apoptotic
778pathways in satellite cells, we cannot exclude the possibility
779that erbB1/2 activation initiates a cascade of extracellular
780signalling between satellite cells and the parent myofibre that
781then indirectly leads to the initiation of apoptosis within the
782satellite cell. For instance, cleavage of erbB2 by caspase-8 in
783MCF7 cancer cells results in their increased susceptibility to
784the pro-apoptotic inflammatory cytokine TNF-α [68,71], also
785expressed within muscle following reperfusion injury [72].
786From a therapeutic perspective, our data suggest that
787inhibitors of erbB2 activity, such as the anti-cancer drug
788Herceptin, may have unforeseen adverse effects on skeletal
789muscleregeneration;whilepromptandacute inhibitionofMEK
790followingmuscle damage could protect at least 15% of satellite
791cells fromcelldeath, thereby increasing theoverall efficiencyof
792adult skeletal muscle regeneration. These results may also
793have relevance both for muscle wasting diseases such as
794cachexia [73]; and for muscular dystrophy, characterised by
795repeated rounds of muscle degeneration and regeneration.
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